# Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients

> **NCT06077214** · PHASE1 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 9 (actual)

## Conditions studied

- Bariatric Surgery Candidate
- Post-operative Pain

## Interventions

- **DRUG:** Treatment with liposomal bupivacaine
- **DRUG:** Treatment with standard bupivacaine

## Key facts

- **NCT ID:** NCT06077214
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-31
- **Primary completion:** 2024-08-20
- **Final completion:** 2024-08-20
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06077214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06077214, "Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06077214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*